FIELD: chemistry.
SUBSTANCE: invention relates to a compound of general formula (I) or a pharmaceutically acceptable salt thereof, in which radicals and symbols assume values given in patent claim. Compound of formula (I) is a kinase inhibitor, such as ALK Abl and/or c-Src.
EFFECT: invention also relates to its use as a drug for treating cancer, inflammation and neurodegenerative diseases, such as Alzheimer's disease, to its use as an inhibitor of said kinases, to a pharmaceutical composition containing said compound, and to methods of its production.
16 cl, 20 tbl, 35 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF AZAINDASOLE OR DIAZAINDASOLE TYPE FOR PAIN TREATMENT | 2013 |
|
RU2640046C2 |
| PYRAZOLO [3,4-C] PYRIDINES AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2638116C2 |
| SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR | 2014 |
|
RU2671212C2 |
| SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
| SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
| NEW COMPOUNDS FOR TREATING AMYLOID OR AMYLOID-LIKE PROTEIN ASSOCIATED DISEASES | 2007 |
|
RU2469026C2 |
| NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITORS, PREPARATION AND USE THEREOF | 2015 |
|
RU2719428C2 |
| LIGANDS FOR AGGREGATED MOLECULES OF TAU-PROTEIN | 2009 |
|
RU2518892C2 |
